| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.28B | 68.13B | 61.26B | 59.59B | 53.48B | 50.36B |
| Gross Profit | 9.64B | 11.02B | 9.29B | 10.60B | 9.98B | 9.23B |
| EBITDA | 3.96B | 4.57B | 3.21B | 4.01B | 4.06B | 3.84B |
| Net Income | 2.02B | 2.90B | 1.85B | 2.00B | 2.35B | 1.98B |
Balance Sheet | ||||||
| Total Assets | 76.48B | 69.11B | 61.75B | 57.05B | 72.17B | 51.39B |
| Cash, Cash Equivalents and Short-Term Investments | 50.81B | 39.98B | 34.81B | 31.16B | 45.95B | 31.07B |
| Total Debt | 5.60B | 629.00M | 1.07B | 1.53B | 1.49B | 1.09B |
| Total Liabilities | 53.28B | 44.23B | 39.45B | 36.27B | 52.50B | 33.78B |
| Stockholders Equity | 22.98B | 24.64B | 22.08B | 20.58B | 19.46B | 17.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.10B | 2.73B | 4.69B | 1.34B | 1.92B |
| Operating Cash Flow | 0.00 | 4.33B | 3.02B | 5.51B | 1.91B | 2.53B |
| Investing Cash Flow | 0.00 | -1.02B | 239.00M | -852.00M | -1.72B | -1.23B |
| Financing Cash Flow | 0.00 | -1.05B | -765.00M | -941.00M | -5.00M | -719.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.19B | 15.44 | ― | 2.18% | 9.87% | 40.32% | |
77 Outperform | ¥28.73B | 8.18 | ― | 2.93% | 7.86% | 28.33% | |
74 Outperform | ¥27.92B | 16.05 | ― | 2.45% | 13.49% | 12.99% | |
71 Outperform | ¥22.28B | 11.39 | ― | 1.70% | 20.32% | 18.86% | |
69 Neutral | ¥30.60B | 13.32 | ― | 2.22% | 11.22% | 55.88% | |
65 Neutral | ¥30.17B | 10.75 | 10.34% | 4.82% | -2.83% | 5.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |